We provide you with 20 years of free, institutional-grade data for VRAX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VRAX. Explore the full financial landscape of VRAX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about VRAX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Virax Biolabs Group Limited(NASDAQ:VRAX) 
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company offers rapid antibody IgC/IgM tests, anti...
Website: https://viraxbiolabs.com
Founded: 2021
IPO Price: $5 (Jul 21, 2022)
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends